Liver fibrosis is an important human health issue associated with chemical exposure. It is a typical result of chronic toxic injury and one of the considered endpoints for regulatory purposes. This AOP describes the linkage between hepatic injury caused by protein alkylation and the formation of liver fibrosis. Fibrogenesis is a long-term and complex process for which an adequate cell model is not available and an in vitro evaluation of fibrogenic potential is therefore not feasible yet. This systematic and coherent display of currently available mechanistic-toxicological information can serve as a knowledge-based repository for identification/selection/development of in vitro methods suitable for measuring key events and their relationships along the AOP and to facilitate the use of alternative data for regulatory purposes. Identified uncertainties and knowledge gaps can indicate priorities for future research.
Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis
Working paper
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Working paper30 June 2025250 Pages
-
30 June 2025329 Pages
-
30 June 2025193 Pages
-
Working paper30 June 2025270 Pages
-
Working paper26 June 202599 Pages
-
12 December 202357 Pages
Related publications
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report2 July 202633 Pages
-
2 July 2026105 Pages
-
2 July 202651 Pages
-
2 July 202620 Pages
-
15 December 2025169 Pages